Compare RUSHA & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RUSHA | RGEN |
|---|---|---|
| Founded | 1965 | 1981 |
| Country | United States | United States |
| Employees | 7355 | N/A |
| Industry | Retail-Auto Dealers and Gas Stations | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6B | 6.6B |
| IPO Year | N/A | 1995 |
| Metric | RUSHA | RGEN |
|---|---|---|
| Price | $76.57 | $131.96 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 12 |
| Target Price | $76.75 | ★ $167.67 |
| AVG Volume (30 Days) | 429.5K | ★ 1.1M |
| Earning Date | 04-28-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.06% | N/A |
| EPS Growth | N/A | ★ 286.96 |
| EPS | N/A | ★ 0.15 |
| Revenue | N/A | ★ $141,236,000.00 |
| Revenue This Year | N/A | $14.30 |
| Revenue Next Year | $5.44 | $14.52 |
| P/E Ratio | ★ $21.36 | $917.33 |
| Revenue Growth | N/A | ★ 35.10 |
| 52 Week Low | $45.67 | $100.99 |
| 52 Week High | $80.17 | $175.77 |
| Indicator | RUSHA | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 59.36 | 44.43 |
| Support Level | $70.00 | $127.63 |
| Resistance Level | $80.17 | $141.46 |
| Average True Range (ATR) | 2.36 | 6.48 |
| MACD | 0.02 | -1.76 |
| Stochastic Oscillator | 64.82 | 24.02 |
Rush Enterprises Inc is a full-service, integrated retailer of commercial vehicles and related services. The company operates in a single segment; Truck Segment includes the operation of a network of commercial vehicle dealerships under the name Rush Truck Centers. It sells commercial vehicles manufactured by Peterbilt, International, Hino, Ford, Isuzu, IC Bus, and Blue Bird and also provides one-stop service for the needs of commercial vehicle customers, including retail sales of new and used commercial vehicles, aftermarket parts sales, service and repair facilities, financing, leasing and rental, and insurance products. The company's business is concentrated in the United States and Ontario, Canada commercial vehicle markets and related aftermarkets.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.